BB Biotech

Swiss company

ISIN CH0038389992 LEI 391200MBZQNPFHIVKO34
Follow BB Biotech Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2022 CHF · IFRS
Net income −CHF 357.8M +11.6% vs prior year
EPS, diluted −CHF 6.50 +11.1% vs prior year
Operating cash flow CHF 231.1M +343.8% vs prior year
Net income by fiscal year
CHF 691.2M
−CHF 404.8M
−CHF 357.8M
FY20 FY21 FY22

Source: ESEF annual reports · latest filing

The long view

Fiscal years as reported · ESEF annual reports, IFRS
Revenue and net income3 fiscal years
−CHF 500MCHF 0CHF 500MCHF 1BFY20FY21FY22
Show the numbers
YearNet income
FY22−CHF 357.8M
FY21−CHF 404.8M
FY20CHF 691.2M
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
CHF 0CHF 100MCHF 200MCHF 300MFY20FY21FY22
Show the numbers
YearDividendsBuybacks
FY22CHF 212.2MCHF 27.3M
FY21CHF 199.4MCHF 9.5M
FY20CHF 188.4MCHF 8.3M